Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Buy
+10,400
New +$3.28M ﹤0.01% 2760
2016
Q1
Sell
-97,200
Closed -$9.03M 3756
2015
Q4
$9.03M Hold
97,200
0.01% 1022
2015
Q3
$9.15M Hold
97,200
0.01% 1011
2015
Q2
$9.29M Hold
97,200
0.01% 1056
2015
Q1
$8.97M Sell
97,200
-76,600
-44% -$7.13M 0.01% 1029
2014
Q4
$16.4M Buy
173,800
+9,500
+6% +$843K 0.02% 812
2014
Q3
$13.3M Buy
164,300
+10,000
+6% +$823K 0.02% 919
2014
Q2
$13M Buy
154,300
+11,600
+8% +$947K 0.02% 932
2014
Q1
$11.6M Buy
142,700
+42,900
+43% +$3.41M 0.02% 961
2013
Q4
$7.5M Buy
99,800
+13,200
+15% +$963K 0.01% 1355
2013
Q3
$5.85M Buy
86,600
+42,900
+98% +$2.96M 0.01% 1456
2013
Q2
$2.83M Buy
+43,700
New +$2.9M 0.01% 1798

Other funds holding SYK

David Shaw's SYK Position: Q2 2026 in Review

David Shaw reduced its Stryker (SYK) stake by 55% in Q2 2026, selling an estimated $104M and leaving 270,554 shares worth $85.2M. The position accounts for 0.04% of the portfolio, ranked #516.

David Shaw first reported a position in SYK in Q2 2013 and has held it in 31 quarters since. The position peaked at $248M in Q1 2025. 2,251 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • David Shaw held 270,554 shares of Stryker worth $85.2M as of Q2 2026.
  • David Shaw sold 330,214 Stryker shares in Q2 2026, an estimated $104M.
  • Stryker made up 0.04% of David Shaw's portfolio in Q2 2026, its #516 holding.
  • David Shaw first reported a position in Stryker in Q2 2013 and has held it in 31 quarters since.
  • David Shaw's Stryker position peaked at $248M in Q1 2025.
  • 2,251 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.